Cargando…
THU669 Time To Achieve Euthyroidism In Graves Disease Using Methimazole In An Urban Population
Disclosure: S.S. Habbsa: None. E. Yunasan: None. A. Krishnan: None. K.M. Munir: None. Context: Previous studies of treatment response in Graves disease have shown that that the mean time to reach euthyroidism with methimazole (MMI) was several weeks to months. In 1987 Okamura et al. concluded that t...
Autores principales: | Sultana Habbsa, Samima, Yunasan, Elvina, Krishnan, Adityanarayan, M, Kashif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555395/ http://dx.doi.org/10.1210/jendso/bvad114.1792 |
Ejemplares similares
-
THU668 Euthyroid Graves’ Ophthalmopathy: Case Series
por: Saleh Alfadl, Sultan, et al.
Publicado: (2023) -
THU655 Methimazole Desensitization As An Effective Alternative To Ablation Therapy In Patients With Graves’ Disease Experiencing Thionamide-induced Type IV Hypersensitivity Reactions
por: Arguinchona, Joseph, et al.
Publicado: (2023) -
SUN-517 Methimazole-Induced Neutropenia in Premature Twins with Graves’ Disease
por: Ballestas, Estefania Rodriguez, et al.
Publicado: (2020) -
A Rare Case of Anaphylaxis to Methimazole in a Patient With Graves’ Disease
por: Garg, Dave, et al.
Publicado: (2021) -
FRI505 A Rare Case Of Methimazole Induced Grave Agranulocytosis
por: Barua, Nabonita, et al.
Publicado: (2023)